EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cutaneous vasculitis in autoinflammatory diseases

Ko-Ron Chen

The Journal of Dermatology · 2024-02 · 51 (2) · 150-159

DOI: 10.1111/1346-8138.17030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Dermatology, online erschienen am 13.11.2023. Verfasst von Ko-Ron Chen. Beteiligte Einrichtung: Meguro Chen Dermatology Clinic, Tokyo, Japan. Hauptthemen laut MEDLINE: Livedo Reticularis, Vasculitis, Polyarteritis Nodosa, Skin Diseases. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoinflammatory diseases (AIDs) characterized by recurrent episodes of localized or systemic inflammation are disorders of the innate immune system. Skin lesions are commonly found in AIDs and cutaneous vasculitis can coexist with AIDs and even present as the most striking feature. This review aims to focus on the frequent cutaneous vasculitis association in three monogenic AIDs including familial Mediterranean fever (FMF), deficiency of adenosine deaminase type 2 (DADA2), and the recently identified adult‐onset VEXAS (vacuoles, E1 enzyme, X‐linked, autoinflammatory, somatic) syndrome. Cutaneous vasculitis in FMF is characterized by: (1) small‐vessel vasculitis similar to IgA vasculitis with palpable purpura but increased intussusception complication and less vascular IgA deposit, and (2) cutaneous arteritis–like vasculitis presenting as subcutaneous nodules most often with higher glomerular involvement. DADA2 has a wide spectrum of clinical presentations ranging from fatal systemic vasculitis with multiple strokes, especially in pediatric patients, to limited cutaneous disease in middle‐aged patients. DADA2 shares similar clinical and histopathological features with polyarteritis nodosa (PAN). As a result, DADA2 is commonly initially misdiagnosed as childhood PAN. Livedo racemosa reveals the most common cutaneous manifestation of cutaneous vasculitis in patients with DADA2. VEXAS syndrome is a life‐threatening disease. A diagnosis of VEXAS syndrome should be strongly considered or could be made in patients with skin lesions characterized by Sweet syndrome–like eruption, livedo racemosa, concomitant relapsing polychondritis, deep venous thrombosis, pulmonary involvement, and progressive hematologic abnormalities such as myelodysplastic syndrome with a unique finding of cytoplasmic vacuoles in myeloid and erythroid precursor cells from bone marrow aspirate smear. As skin involvement is common in AIDs and may present as the most frequent manifestation, especially in DADA2 (70% to 90%) and VEXAS syndrome (83% to 91%), dermatologists play a crucial role in contributing to the early diagnosis of these AIDs with early initiation of the appropriate therapy to avoid progressing fatal outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Livedo ReticularisVasculitisPolyarteritis NodosaSkin DiseasesFamilial Mediterranean FeverAgammaglobulinemiaMyelodysplastic SyndromesSkin Diseases, GeneticSevere Combined ImmunodeficiencyAdultHumansChildMiddle AgedAdenosine DeaminaseIntercellular Signaling Peptides and ProteinsMutation

Stichwörter der Autor:innen

AIDsDADA2FMFVEXAScutaneous vasculitislivedo racemosa

Substanzen

Adenosine DeaminaseIntercellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Meguro Chen Dermatology Clinic, Tokyo, Japan.

Zitieren

APA

Chen, K. R. (2024). Cutaneous vasculitis in autoinflammatory diseases. The Journal of Dermatology, 51(2), 150-159. https://doi.org/10.1111/1346-8138.17030

Vancouver

Chen KR. Cutaneous vasculitis in autoinflammatory diseases. The Journal of Dermatology. 2024;51(2):150-159. doi:10.1111/1346-8138.17030

BibTeX
@article{Chen2024,
  author = {Chen, Ko-Ron},
  title = {Cutaneous vasculitis in autoinflammatory diseases},
  journal = {The Journal of Dermatology},
  year = {2024},
  volume = {51},
  number = {2},
  pages = {150--159},
  doi = {10.1111/1346-8138.17030}
}
Kostenlos starten →